We are live on ! Find out more
AIP

ARS Investment Partners Portfolio holdings

AUM $2.29B
1-Year Est. Return 113.95%
This Fund
S&P 500
This Quarter Est. Return
+13.9%
1 Year Est. Return
+113.95%
3 Year Est. Return
+260.1%
5 Year Est. Return
+332.48%
10 Year Est. Return
+1,634.5%
AUM
$752M
AUM Growth
+$24.5M
Cap. Flow
-$39.7M
Cap. Flow %
-5.28%
Top 10 Hldgs %
41.14%
Holding
190
New
11
Increased
35
Reduced
78
Closed
42

Sector Composition

Rank Sector Weight
1 Technology 23.65%
2 Materials 15.79%
3 Industrials 15.49%
4 Communication Services 10.09%
5 Healthcare 9.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SBUX icon
176
Starbucks
SBUX
$120B
-1,246
Closed -$105K
SONY icon
177
Sony
SONY
$138B
-16,500
Closed -$211K
STX icon
178
Seagate
STX
$184B
-15,390
Closed -$819K
TIGO icon
179
Millicom
TIGO
$16.3B
-10,000
Closed -$114K
TSLA icon
180
Tesla
TSLA
$1.3T
-1,875
Closed -$497K
UIS icon
181
Unisys
UIS
$217M
-52,684
Closed -$398K
VTRS icon
182
Viatris
VTRS
$18.9B
-12,169
Closed -$104K
WBS icon
183
Webster Financial
WBS
$12.8B
-20,211
Closed -$914K
XPO icon
184
XPO
XPO
$23.7B
-20,221
Closed -$535K
CONX
185
DELISTED
CONX Corp. Class A Common Stock
CONX
-38,000
Closed -$380K
KAMN
186
DELISTED
Kaman Corp
KAMN
-7,236
Closed -$202K
LMACW
187
DELISTED
Liberty Media Acquisition Corporation Warrants
LMACW
-45,000
Closed
LMACA
188
DELISTED
Liberty Media Acquisition Corporation Series A Common Stock
LMACA
-18,000
Closed -$179K
TWTR
189
DELISTED
Twitter, Inc.
TWTR
-5,200
Closed -$228K
BHVN
190
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
-45,892
Closed -$6.94M

Similar funds

ARS Investment Partners's Q4 2022 Portfolio in Review

As of Q4 2022, ARS Investment Partners held 190 positions worth $752M, up 3.4% from $727M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

ARS Investment Partners withdrew a net $39.7M in Q4 2022, closing 42 positions and reducing 78 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $6.94M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Materials and Industrials.

Against the trend, ARS Investment Partners opened a new position in Biohaven worth $7.83M.

  • ARS Investment Partners's largest Q4 2022 buy was Biohaven: 564,239 shares worth $7.83M.
  • ARS Investment Partners added most to Charter Communications in Q4 2022, an estimated $13.6M increase.
  • ARS Investment Partners's biggest Q4 2022 reduction was Apple, cutting an estimated $8.45M.
  • ARS Investment Partners fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $6.94M.
  • ARS Investment Partners's ten largest holdings make up 41% of its $752M portfolio in Q4 2022.
  • ARS Investment Partners opened 11 new positions and closed 42 in Q4 2022.
  • ARS Investment Partners's portfolio value rose 3.4% quarter-over-quarter to $752M.

Based on ARS Investment Partners's 13F filing for Q4 2022, filed 25 Jan 2023.